Katharine E. Spink
2013
In 2013, Katharine E. Spink earned a total compensation of $456.6K as Vice President and Chief Operating Officer at Asterias Biotherapeutics.
Compensation breakdown
| Option Awards | $293,898 |
|---|---|
| Salary | $157,500 |
| Other | $5,156 |
| Total | $456,554 |
Spink received $293.9K in option awards, accounting for 64% of the total pay in 2013.
Spink also received $157.5K in salary and $5.2K in other compensation.
Rankings
In 2013, Katharine E. Spink's compensation ranked 9,646th out of 12,286 executives tracked by ExecPay. In other words, Spink earned more than 21.5% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 9,646 out of 12,286 | 22nd |
Division Manufacturing | 3,572 out of 4,612 | 23rd |
Major group Chemicals And Allied Products | 1,128 out of 1,462 | 23rd |
Industry group Drugs | 875 out of 1,156 | 24th |
Industry Biological Products, Except Diagnostic Substances | 147 out of 196 | 25th |
Source: SEC filing on June 10, 2015.
Spink's colleagues
We found three more compensation records of executives who worked with Katharine E. Spink at Asterias Biotherapeutics in 2013.